# Specification Quality Checklist: Catálogo de medicamentos

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-09-05
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [ ] No [NEEDS CLARIFICATION] markers remain — bloqueado a propósito hasta `/speckit-clarify` (Q1, forma farmacéutica)
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- Items marked incomplete require spec updates before `/speckit-clarify` or `/speckit-plan`.
- Único punto pendiente: Q1 (§9 de spec.md) sobre si la lista cerrada de formas farmacéuticas
  (FR-300) necesita más valores. La propia spec original ya trae una propuesta por defecto
  ("ampliable sin romper nada"), así que se resolverá en una sola pregunta en `/speckit-clarify`.
